-
1
-
-
0003700389
-
-
Bethesda, MD: American Society of Health-System Pharmacists
-
McEvoy GK, ed. AHFS drug information 99. Bethesda, MD: American Society of Health-System Pharmacists; 1999.
-
(1999)
AHFS Drug Information 99
-
-
McEvoy, G.K.1
-
2
-
-
0029658194
-
Rapid heparin anticoagulation: Use of a weight-based nomogram
-
Schaefer DC, Hufnagle J, Williams L. Rapid heparin anticoagulation: use of a weight-based nomogram. Am Fam Physician. 1996; 54:2517-21.
-
(1996)
Am Fam Physician
, vol.54
, pp. 2517-2521
-
-
Schaefer, D.C.1
Hufnagle, J.2
Williams, L.3
-
3
-
-
0027517894
-
The weight-based heparin dosing nomogram compared with a "standard care" nomogram
-
Raschke RA, Reilly BM, Guidry JR et al. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med. 1993; 119: 874-81.
-
(1993)
Ann Intern Med
, vol.119
, pp. 874-881
-
-
Raschke, R.A.1
Reilly, B.M.2
Guidry, J.R.3
-
4
-
-
0031690335
-
Weight-based heparin dosing: Clinical response and resource utilization
-
Lackie CL, Luzier AB, Donovan JA et al. Weight-based heparin dosing: clinical response and resource utilization. Clin Ther. 1998; 20:699-710.
-
(1998)
Clin Ther
, vol.20
, pp. 699-710
-
-
Lackie, C.L.1
Luzier, A.B.2
Donovan, J.A.3
-
5
-
-
33847591386
-
Applied pharmacokinetics: Principles of therapeutic drug monitoring
-
Evans WE, Schentag JJ, Jusko WJ et al., eds. Vancouver, WA
-
Cipolle RJ, Rodvold KA. In: Evans WE, Schentag JJ, Jusko WJ et al., eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. Vancouver, WA: Applied Therapeutics; 1992:30-1-39.
-
(1992)
Applied Therapeutics
-
-
Cipolle, R.J.1
Rodvold, K.A.2
-
6
-
-
0031937523
-
Optimal weight base for a weight-based heparin dosing protocol
-
Yee WP, Norton LL. Optimal weight base for a weight-based heparin dosing protocol. Am J Health-Syst Pharm. 1998; 55:159-62.
-
(1998)
Am J Health-Syst Pharm
, vol.55
, pp. 159-162
-
-
Yee, W.P.1
Norton, L.L.2
-
7
-
-
0028785452
-
Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
-
Hirsh J, Raschke R, Warkentin TE et al. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest. 1995; 108:258S-75S.
-
(1995)
Chest
, vol.108
-
-
Hirsh, J.1
Raschke, R.2
Warkentin, T.E.3
-
8
-
-
0023913277
-
Physician practices in the treatment of pulmonary embolism and deep vein thrombosis
-
Wheeler AP, Jaquiss RD, Newman JH. Physician practices in the treatment of pulmonary embolism and deep vein thrombosis. Arch Intern Med. 1988; 148: 1321-5.
-
(1988)
Arch Intern Med
, vol.148
, pp. 1321-1325
-
-
Wheeler, A.P.1
Jaquiss, R.D.2
Newman, J.H.3
-
9
-
-
0034650447
-
Partnering with nurses to manage heparin therapy with a weight-based protocol
-
Price CK, Colodny L. Partnering with nurses to manage heparin therapy with a weight-based protocol. Am J Health-Syst Pharm. 2000; 57:110-6.
-
(2000)
Am J Health-Syst Pharm
, vol.57
, pp. 110-116
-
-
Price, C.K.1
Colodny, L.2
-
10
-
-
0032534910
-
Pharmacoeconomic impact of a weight-based heparin protocol
-
Bowden C, Carter K, Birtcher K et al. Pharmacoeconomic impact of a weight-based heparin protocol. Am J Health-Syst Pharm. 1998; 55(suppl):S29-32.
-
(1998)
Am J Health-Syst Pharm
, vol.55
, Issue.SUPPL.
-
-
Bowden, C.1
Carter, K.2
Birtcher, K.3
-
11
-
-
0003061231
-
A weight-based heparin protocol for improved anticoagulation in a coronary care unit
-
Pinder T, Daughtry W, Shah Z et al. A weight-based heparin protocol for improved anticoagulation in a coronary care unit. J Clin Outcomes Manage. 1999; 6(5): 27-33.
-
(1999)
J Clin Outcomes Manage
, vol.6
, Issue.5
, pp. 27-33
-
-
Pinder, T.1
Daughtry, W.2
Shah, Z.3
|